We used a central computerised phone or interactive web system to randomly assign ( @:@ ) patients at high risk of morbidity and mortality from @ hospital or cardiac surgery centres in @ countries undergoing cardiac surgery with the use of cardiopulmonary bypass to receive either methylprednisolone ( @ mg at anaesthetic induction and @ mg at initiation of cardiopulmonary bypass ) or placebo .